Other malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Clinical Oncology

• Publication date

  2006-11-16

• Fields of study

  Medicine

• Identifiers
  DOI 10.1200/JCO.2008.17.5398PMID 19114699PMCID PMC4979239
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Assessment of chronic lymphocytic leukemia and small lymphocytic lymphoma by absolute lymphocyte counts in 2,126 patients: 20 years of experience at the University of Texas M.D. Anderson Cancer Center.

  2007cited by this paper
• Seventy percent of complete responders remain in continuous remission: Five-year follow-up of 300 patients treated with fludarabine, cyclophosphamide, and rituximab (FCR) as initial therapy of CLL

  2007cited by this paper
• Cancer survivorship--genetic susceptibility and second primary cancers: research strategies and recommendations.

  2006influential reference
• Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemia.

  2005cited by this paper
• Richter's syndrome--the downside of fludarabine?

  2005influential reference
• Fludarabine and mitoxantrone for patients with chronic lymphocytic leukemia

  2004cited by this paper
• High incidence of complications after 2-chloro-2’-deoxyadenosine combined with cyclophosphamide in patients with advanced lymphoproliferative malignancies

  2004cited by this paper
• Results of the fludarabine and cyclophosphamide combination regimen in chronic lymphocytic leukemia.

  2001cited by this paper
• Safety of fludarabine, mitoxantrone, and dexamethasone combined with rituximab in the treatment of stage IV indolent lymphoma.

  2000cited by this paper
• Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group.

  1999cited by this paper
• Second malignancies as a consequence of nucleoside analog therapy for chronic lymphoid leukemias.

  1999influential reference
• National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment.

  1996cited by this paper
• Radiotherapy, alkylating agents, and risk of bone cancer after childhood cancer.

  1996cited by this paper
• Long-term follow-up of patients with chronic lymphocytic leukemia treated with fludarabine as a single agent.

  1993cited by this paper
• Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis-derived prognostic model for response to treatment.

  1993cited by this paper
• Second cancers in patients with chronic lymphocytic leukemia.

  1992cited by this paper
• Fludarabine: a new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemia.

  1991cited by this paper
• Subsequent cancer in patients with chronic lymphocytic leukemia--a possible immunologic mechanism.

  1978cited by this paper
• Subsequent neoplasia in chronic lymphocytic leukemia.

  1975cited by this paper

• Extranodal Manifestation of Chronic Lymphocytic Leukemia: A Case of Bilateral Breast Involvement

  2025cites this paper
• Immune Dysfunction and Consequences in Chronic Lymphocytic Leukemia.

  2025cites this paper
• Chemoprevention of Keratinocyte Cancers: Could Aspirin Be the Solution?

  2025influential citation
• Incidence and impact of other malignancies after immunochemotherapy by fludarabine, cyclophosphamide, and rituximab as frontline treatment for chronic lymphocytic leukemia: A single-center retrospective study.

  2025cites this paper
• Management of multiple primary prostate malignant tumors: case report of synchronous prostatic adenocarcinoma and lymphoma

  2025cites this paper
• Uncommon Manifestations of Newly Diagnosed B-cell Chronic Lymphocytic Leukemia Prompting the Concurrent Diagnosis of Advanced Prostate Cancer: A Case Report

  2025cites this paper
• Do hematologic malignancies cause a barrier for sentinel lymph node mapping in endometrial cancer? A case report

  2024cites this paper
• Risk of Incident Melanoma Among Individuals With Low-Count Monoclonal B-Cell Lymphocytosis

  2024cites this paper
• Investigating the influence of germline ATM variants in chronic lymphocytic leukemia on cancer vulnerability

  2024cites this paper
• Lymphoma combined with lung cancer: A case report

  2024cites this paper
• Adverse In-Hospital Outcomes after Radical Prostatectomy in Leukemia History Patients

  2024cites this paper
• Melanoma as Subsequent Primary Malignancy in Hematologic Cancer Survivors—A Literature Review

  2024cites this paper
• Fludarabine, cyclophosphamide, and rituximab as first‐line treatment in patients with chronic lymphocytic leukemia: A long‐term analysis of the German CLL Study Group (GCLLSG) registry

  2024cites this paper
• Secondary Histiocytic Sarcoma in a Pre-B-Acute Lymphoblastic Leukemia

  2024cites this paper
• Ibrutinib in Early-Stage Chronic Lymphocytic Leukemia: The Randomized, Placebo-Controlled, Double-Blind, Phase III CLL12 Trial

  2024cites this paper
• Incidence of cutaneous melanoma and Merkel cell carcinoma in patients with primary cutaneous B-cell lymphomas: A population study of the SEER registry

  2023cites this paper
• Cutaneous Squamous Cell Carcinoma in Immunocompromised Patients—A Comparison between Different Immunomodulating Conditions

  2023cites this paper
• Risk of second primary malignancies in patients with chronic lymphocytic leukemia: a population-based study in the Netherlands, 1989-2019

  2023cites this paper
• Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY

  2023cites this paper
• Safety of radiotherapy for second primary malignancies in patients with chronic lymphocytic leukemia receiving concurrent novel agent treatment

  2023cites this paper
• A population level analysis of second hematological malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma survivors in the era of targeted therapies

  2023cites this paper
• Evaluation of Second Primary Cancer Risk Among Chronic Lymphocytic Leukemia Patients: Multicenter Study

  2023influential citation
• Concomitant Venetoclax and Imatinib for Comanaging Chronic Lymphocytic Leukemia and Chronic Myeloid Leukemia: A Case Report.

  2023cites this paper
• Chronic lymphocytic leukaemia Australasian consensus practice statement

  2023cites this paper
• Hematologic secondary malignancies among 102 Chinese patients with Waldenstrom’s macroglobulinemia: a single-center case experience and literature review

  2023cites this paper
• Multiple primary malignancies in 788 Chinese patients with diffuse large B‐cell lymphoma

  2023cites this paper
• How We Manage Patients with Indolent B-Cell Malignancies on Bruton’s Tyrosine Kinase Inhibitors: Practical Considerations for Nurses and Pharmacists

  2023cites this paper
• Therapy related AML in a case of chronic lymphocytic leukemia.

  2023cites this paper
• Synchronous oral squamous cell carcinoma and a lymphoproliferative disorder in an adult: a challenge in diagnosis and management

  2022cites this paper
• Frequency and timing of other primary cancers in patients with chronic lymphocytic leukemia (CLL): a 17-year longitudinal study

  2022cites this paper
• Secondary primary malignancies after treatment with chemo-immunotherapy in treatment-naïve patients with CLL: a systematic literature review

  2022influential citation
• An Unusual Case of Chronic Lymphocytic Leukaemia Involving the Cervix

  2022cites this paper
• Primary cutaneous gamma‐delta T‐cell lymphoma masquerading as leukemia cutis in a patient recently diagnosed with small lymphocytic lymphoma: Clues to the diagnosis

  2022cites this paper
• Co‐existence of chronic lymphocytic leukemia and chronic myeloid leukemia and underlying pathogenetic mechanisms

  2022cites this paper
• Leveraging electronic health record data for clinical trial planning by assessing eligibility criteria's impact on patient count and safety

  2022cites this paper
• Synchronous renal pelvis carcinoma associated with small lymphocytic lymphoma: A case report

  2022cites this paper
• Merkel cell carcinoma and follicular lymphoma: A highly unusual collision tumor

  2022cites this paper
• Long-term outcomes for ibrutinib–rituximab and chemoimmunotherapy in CLL: updated results of the E1912 trial

  2022influential citation
• Role of social status and social environment on net survival in patients with chronic lymphocytic leukemia: A high-resolution population-based study.

  2022cites this paper
• Monoclonal B-cell Lymphocytosis – a review of diagnostic criteria, biology, natural history, and clinical management

  2022cites this paper
• Therapy-related Myeloid Neoplasms in Patients With Chronic Lymphocytic Leukemia Who Received FCR/FC as Frontline Therapy

  2022cites this paper
• Merkel cell carcinoma in the setting of hematologic disease is associated with unique features and potential pitfalls.

  2021cites this paper
• Merkel Cell Carcinoma in the Setting of Chronic Lymphocytic Leukemia and Diffuse Large B-Cell Lymphoma

  2021cites this paper
• Risk of new malignancies among patients with CLL treated with chemotherapy: results of a Danish population‐based study

  2021cites this paper
• Second primary malignancies in chronic lymphocytic leukaemia: Skin, solid organ, haematological and Richter's syndrome

  2021cites this paper
• Early intervention in asymptomatic chronic lymphocytic leukemia.

  2021cites this paper
• Coexistence of Endometrial Cancer and Nodal Non-Hodgkin Lymphoma: A Case Series

  2021cites this paper
• Ibrutinib Treatment and EGFR-mutant Lung Adenocarcinoma.

  2021cites this paper
• A POLE Splice Site Deletion Detected in a Patient with Biclonal CLL and Prostate Cancer: A Case Report

  2021cites this paper
• Incidental chronic lymphocytic leukemia diagnosed following radical prostatectomy for prostate cancer: A case report

  2021cites this paper
• Bladder Lymphoma and Leukemia

  2021cites this paper
• Microsurgical techniques in the treatment of breast cancer-related lymphedema: a systematic review of efficacy and patient outcomes

  2021cites this paper
• Metastatic Breast Cancer Presenting as Pulmonary Nodules and Right Axillary Lymph Node in a Male with Chronic Lymphocytic Leukemia

  2021cites this paper
• Pleural Effusions in Hematologic Diseases – A Narrative Review

  2021cites this paper
• Impact of Immune Parameters and Immune Dysfunctions on the Prognosis of Patients with Chronic Lymphocytic Leukemia

  2021cites this paper
• Cutaneous Head and Neck Cancers in the High-Risk Immunosuppressed Population.

  2021cites this paper
• Detailing the epidemiological and clinical characteristics of chronic lymphocytic leukaemia in Portugal—Results from a population-based cancer registry cohort study

  2021cites this paper
• In vivo, ex vivo and in vitro dasatinib activity in chronic lymphocytic leukemia

  2021cites this paper
• Restoration of the immune function as a complementary strategy to treat Chronic Lymphocytic Leukemia effectively

  2021cites this paper
• Common genetic polymorphisms contribute to the association between chronic lymphocytic leukaemia and non-melanoma skin cancer.

  2021cites this paper
• Multiple B cell malignancies in patients with chronic lymphocytic leukemia: epidemiology, pathology, and clinical implications

  2020cites this paper
• University of Southern Denmark Long Term Follow-up Data and Health-Related Quality of Life in Frontline Therapy of Fit Patients Treated With FCR Versus BR (CLL10 Trial of the GCLLSG) Kutsch,

  2020cites this paper
• Long Term Follow-up Data and Health-Related Quality of Life in Frontline Therapy of Fit Patients Treated With FCR Versus BR (CLL10 Trial of the GCLLSG)

  2020cites this paper
• Clinical considerations about the coexistence of melanoma and chronic lymphocytic leukemia in the era of targeted therapies, triggered by rare clinical scenarios. A case series and review of the literature

  2020cites this paper
• Biphasic Squamoid Alveolar Renal Cell Carcinoma of the Kidney Involved by Atypical CD5-Positive B-Cells

  2020cites this paper
• Hydroa Vacciniforme-Like Lymphoproliferative Disorder in an Adult Patient With Chronic Lymphocytic Leukemia

  2020cites this paper
• Chronic lymphocytic leukemia and Second Primary Malignancies: A Relationship Revisited

  2020cites this paper
• Bilateral breast implant associated chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): A case report

  2020cites this paper
• Chronic lymphocytic leukemia with progressive anemia secondary to development of composite lymphoma

  2020cites this paper
• Characterization of environmental and genetic factors in multiple-case lymphoid cancer families

  2020cites this paper
• Co-Existence of Chronic Lymphocytic Leukaemia and Malignancy of Uterine Cervix

  2020cites this paper
• Chronic lymphoproliferative disorders and secondary cancers in the era of purine analogues and beyond

  2020cites this paper
• Phase Ib Study of Tirabrutinib in Combination with Idelalisib or Entospletinib in Previously Treated Chronic Lymphocytic Leukemia

  2020cites this paper
• Delineation of clinical and biological factors associated with cutaneous squamous cell carcinoma amongst chronic lymphocytic leukemia patients.

  2020cites this paper
• Features of cytogenetic diagnosis of simultaneous chronic lymphocytic leukemia and myelodysplastic syndrome: clinical case report

  2019cites this paper
• Chronic lymphocytic leukemia revealed by a rare complication: Noma. First description from Togo

  2019cites this paper
• Extended lymphadenectomy for high-risk prostate cancer in patients with chronic lymphocytic leukemia may not be necessary: a report of two cases

  2019influential citation
• Targeting BTK in CLL: Beyond Ibrutinib

  2019cites this paper
• Trends in the risk of second primary malignancies among survivors of chronic lymphocytic leukemia

  2019cites this paper
• Risk factors for skin cancer and solid tumors in newly diagnosed patients with chronic lymphocytic leukemia and the impact of skin surveillance on survival

  2019influential citation
• Safety and efficacy analysis of long-term follow up real-world data with ibrutinib monotherapy in 58 patients with CLL treated in a single-center in Greece

  2019cites this paper
• Second Cancer Incidence in CLL Patients Receiving BTK Inhibitors

  2019cites this paper
• Elevated IgM and abnormal free light chain ratio are increased in relatives from high-risk chronic lymphocytic leukemia pedigrees

  2019cites this paper
• Comparison of tumor staging systems for cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia

  2019cites this paper
• The Clinical Presentation of CLL

  2019cites this paper
• Chronic Lymphocytic Leukemia Presenting as Irritative Lower Urinary Tract Symptoms and Non-visible Hematuria: An Atypical Urology Presentation

  2019cites this paper
• CLL and CML sometimes meet and circulate together

  2019cites this paper
• Monoclonal B-cell lymphocytosis and prostate cancer: incidence and effects of radiotherapy

  2019cites this paper
• Concurrent Squamous Cell Carcinoma and Chronic Lymphocytic Leukemia Presenting as an Enlarging Neck Mass

  2019cites this paper
• Risk of Head and Neck Cancer in Patients With Prior Hematologic Malignant Tumors.

  2019cites this paper
• Chronic lymphocytic leukemia, skin and other second cancers

  2019influential citation
• Nachsorge bei Krebs: ausgewählte solide Tumore und hämatologische Neoplasien

  2018cites this paper
• Morphological, immunophenotypic, and genetic features of chronic lymphocytic leukemia with trisomy 12: a comprehensive review

  2018cites this paper
• Primer on Chronic Lymphocytic Leukemia: Part I

  2018cites this paper
• Allogeneic stem cell transplantation as a risk factor for recurrent melanoma

  2018influential citation
• Prevalence of cutaneous viral infections in incident cutaneous squamous cell carcinoma detected among chronic lymphocytic leukemia and hematopoietic stem cell transplant patients

  2018cites this paper
• Skin Cancers Associated with Lymphoid Malignancies

  2018cites this paper
• Chronic Lymphocytic Leukemia and solid and hematological second neoplasms: a real association?

  2018cites this paper
• Secondary primary malignancy presence and related factors in chronic lymphocytic leukemia

  2018cites this paper
• Studies of Bruton’s tyrosine kinase inhibitors in B-cell malignancies

  2018cites this paper